A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3889-3896

  Sucunza Alfonso, Nuria ^a,b   Barahona, M José ^a,c   Resmini, Eugenia ^a   Fernández Real, Jose Manuel ^d   Ricart, Wifredo ^d   Farrerons, Jordi ^a   Rodríguez Espinosa, José ^a   Marin, Ana María ^a   Puig, Teresa ^a   Webb, Susan M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE MANACOR   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CARBOXY TERMINAL TELOPEPTIDE; GROWTH HORMONE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACROMEGALY; ARTICLE; BLOOD CHEMISTRY; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE METABOLISM; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 70349902771     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0474     Document Type: Article

References (44)

1. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M 2003 Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243 (Pubitemid 36173174)
2. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935 (Pubitemid 32472900)
3. Sobngwi E, Effoe V, Boudou P, Njamen D, Gautier JF, Mbanya JC 2007 Waist circumference does not predict circulating adiponectin levels in sub-Saharan women. Cardiovasc Diabetol 6:31 (Pubitemid 350193888)
4. Pajvani UB, Scherer PE 2003 Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 3:207-213 (Pubitemid 38906774)
5. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipocyte specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83 (Pubitemid 29299050)
6. Haque WA, Shimomura I, Matsuzawa Y, Garg A 2002 A Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87:2395 (Pubitemid 34521536)
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599 (Pubitemid 30353893)
8. Matsubara M, Maruoka S, Katayose S 2002 Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-2769 (Pubitemid 34655342)
9. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y 2003 Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16:72-75 (Pubitemid 36078595)
10. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y. Osaka CAD Study Group Coronary artery disease 2003 Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89 (Pubitemid 36091630)
11. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD 2007 Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 92:1517-1523 (Pubitemid 46556433)
12. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN 2004 Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546-551
13. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY 2008 Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 387:31-35 (Pubitemid 350050925)
14. Lam KS, Xu A, Tan KC, Wong LC, Tiu SC, Tam S 2004 Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab 89:5448-5453 (Pubitemid 39518424)
15. Ronchi CL, Corbetta S, Cappiello V, Morpurgo PS, Giavoli C, Beck-Peccoz P, Arosio M, Spada A 2004 Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients. Eur J Endocrinol 150:663-669 (Pubitemid 38786536)
16. Silha JV, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, Murphy LJ 2003 Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol (Oxf) 58:736-742 (Pubitemid 36702734)
17. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
18. Tamura T, Yoneda M, Yamane K, Nakanishi S, Nakashima R, Okubo M, Kohno N 2007 Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism 56:623-628 (Pubitemid 46574724)
19. The Third Report of the National Cholesterol Education Program (NECP) 2001 Expert Panel on Detection Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497
20. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M 2004 Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA). Eur J Endocrinol 151:439-446 (Pubitemid 39430260)
21. Bengtsson BA, Brummer RJ, Edén S, Bosaeus I, Lindstedt G 1989 Body composition in acromegaly: the effect of treatment. Clin Endocrinol (Oxf) 31:481-490 (Pubitemid 19238231)
22. Kaji H, Sugimoto T, Nakaoka D, Okimura Y, Kaji H, Abe H, Chihara K 2001 Bone metabolism and body composition in Japanese patients with active acromegaly. Clin Endocrinol (Oxf) 55:175-181 (Pubitemid 32868581)
23. Hansen TB, Gram J, Bjerre P, Hagen C, Bollerslev J 1994 Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study. Clin Endocrinol (Oxf) 41:323-329 (Pubitemid 24278326)
24. Díez JJ, Iglesias P 2003 The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293-300 (Pubitemid 36410714)
25. Manco M, Fernandez-Real JM, Equitani F, Vendrell J, Valera Mora ME, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M, Mingrone G 2007 Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 92:483-490 (Pubitemid 46255284)
26. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819 (Pubitemid 32755982)
27. Guerre-Millo M 2002 Adipose tissue hormones. J Endocrinol Invest 25:855-861
28. Gualillo O, González-Juanatey JR, Lago F 2007 The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med 17:275-283 (Pubitemid 350087698)
29. Katznelson L 2009 Alterations in body composition in acromegaly. Pituitary 12:136-142
30. Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P 2007 In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender. Neuro Endocrinol Lett 28:621-628
31. Bolanowski M, Daroszewski J, Zatonska K, Arkowska A 2006 Circulating cytokines in relation to bone mineral density changes in patients with acromegaly. Neuro Endocrinol Lett 27:183-188 (Pubitemid 43970791)
32. Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, DeMarinis L, Giustina A 2008 Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93: 4649-4655
33. Sucunza N, Barahona MJ, Resmini E, Fernández-Real JM, Farrerons J, Lluch P, Puig T, Wägner AM, Ricart W, Webb SM 2008 Gender dimorphism in body composition abnormalities in acromegaly. Males are more affected than females. Eur J Endocrinol 159:773-779
34. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW 2003 Adiponectin as a novel determinantofbonemineraldensityandvisceral fat. Bone 33:646-651
35. Jürimäe J, Jürimäe T 2007 Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int 18:1253-1259 (Pubitemid 47300275)
36. Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW 2005 The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 63:131-138
37. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE 2004 Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842-849 (Pubitemid 39349215)
38. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY 2006 Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648-1656 (Pubitemid 44484610)
39. Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J 2006 Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur J Endocrinol 155:709-715 (Pubitemid 44857495)
40. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B 2009 Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827-832
41. Fernández-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gómez-Ambrosi J, Moreno-Navarrete JM, Frühbeck G, Martínez C, Idoate F, Salvador J, Forga L, Ricart W, Ibañ ez J 2009 The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 94:237-245
42. Gerdhem P, Isaksson A, Akesson K, Obrant KJ 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506-1512 (Pubitemid 41790853)
43. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T 2009 Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:45-49
44. Boguslawski G, Hale LV, Yu XP, Miles RR, Onyia JE, Santerre RF, Chandrasekhar S 2000 Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways. J Biol Chem 275:999-1006 (Pubitemid 30051146)